Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Narrow forehead, Bilateral tonic-clonic seizure, Delayed CNS myelination, and Cerebral cortical atrophy and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Bilateral tonic-clonic seizure, Cerebral cortical atrophy, Nerve damage affecting sensation and movement (sensorimotor neuropathy) |
GET4 encodes guided entry of tail-anchored proteins factor 4 (327 aa). As part of a cytosolic protein quality control complex, the BAG6/BAT3 complex, maintains misfolded and hydrophobic patches-containing proteins in a soluble state and participates in their proper delivery to the endoplasmic reticulum or alternatively can promote their sorting to the proteasome where they undergo degradation. Highest expression in Testis (12.2 TPM) and Pituitary (6.1 TPM).
Congenital disorder of glycosylation, type IIy is associated with mutations in the GET4 gene on chromosome 7.
The GET4 protein participates in Tail-anchored protein:SGTA:BAG6:GET4:UBL4A:ASNA1:ATP, Mislocalized membrane protein:SGTA:BAG6:GET4:UBL4A:ASNA1:ATP, and Insertion of tail-anchored proteins into the endoplasmic reticulum membrane pathways.
GET4 is classified as a druggable target with score 0.0.
Genetic testing for GET4 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 23 always present features.
No clinical trials have been registered for congenital disorder of glycosylation, type IIy.
1 publication has been identified in PubMed for congenital disorder of glycosylation, type IIy. Research spans Review / Meta-Analysis (100%).
Furuta Y (2024). [PMID: 39543639](https://pubmed.ncbi.nlm.nih.gov/39543639/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 21, 2026, 4:52 AM UTC
Online Mendelian Inheritance in Man
Common questions about congenital disorder of glycosylation, type IIy
Muscles |
3 |
Cerebral cortical atrophy, Low muscle tone (hypotonia), Atrophy/Degeneration affecting the brainstem |
Bones and joints | 3 | Sideways curvature of the spine (scoliosis), Delayed skeletal maturation, Low bone density (reduced bone mineral density) |
Head and neck | 1 | Microcephaly |